Morten Sogaard, vice president of Target Sciences, Emerging Science & Innovation, for Pfizer, noted the company’s mRNA vaccine has an advantage because the company can “alter the sequence of the RNA very easily.”
from News https://www.ctpost.com/news/article/Pfizer-VP-Vaccine-can-be-adapted-to-fight-COVID-16108841.php
No comments:
Post a Comment